Abstract
Diabetes mellitus (DM) is a complex disease that affects many systems. The most important cells of the immune system are lymphomononuclear (LMN) cells. Here, we aimed to evaluate the energy metabolism of LMN cells in patients with diabetes and impaired glucose tolerance. We measured LMN cell energy metabolism in patients with type 2 diabetes mellitus, impaired glucose tolerance (IGT) and healthy subjects. Cells were freshly isolated from peripheral blood and the subgroups were determined by flow cytometric method. Lactate production and glycogen utilization were significantly increased in the LMN cells of patients with type 2 DM and IGT when compared with healthy volunteers. No statistical difference was observed between the patients with type 2 DM and IGT. There was a significant correlation between fasting plasma glucose and lactate production in LMN cells. LMN cells changed their energy pathway in a diabetic state and preferred anaerobic glycolysis. Prediabetic range also affected energy metabolism in LMN cells. This abnormal energy production might cause dysfunction in LMN cells and the immune system in diabetic and prediabetic patients. In conclusion, we concluded that impaired glucose metabolism could change energy metabolism.
Similar content being viewed by others
References
P. Froguel, G. Velho, Genetic determinants of type 2 diabetes. Recent Prog. Horm. Res. 56, 91–105 (2001)
M. Guvener, I. Pasaoglu, M. Demircin, M. Oc, Preoperative hyperglycemia is a strong correlate of postoperative infection in type II diabetic patients after coronary artery bypass grafting. Endocr. J. 49, 531–537 (2002)
A. Bensadoun, D. Weinstein, Assay of proteins in the presence of interfering materials. Anal. Biochem. 70, 241–250 (1976)
D. Reinhold, S. Ansorge, E.D. Schleicher, Elevated glucose levels stimulate transforming growth factor-_1 (TGF-_1), suppress interleukin IL-2, IL-6 and IL-10 production and DNA synthesis in peripheral blood mononuclear cells. Horm. Metab. Res. 28, 267–270 (1996)
S.E. Geerlings, E.C. Brouwer, K.C. Van Kessel, W. Gaastra, R.P. Stolk, A.I. Hoepelman, Cytokine secretion is impaired in women with diabetes mellitus. Eur. J. Clin. Invest. 30(11), 995–1001 (2000)
M. Delamaire, D. Maugendre, M. Moreno, M.C. Le Goff, H. Allannic, B. Genetet, Impaired leucocyte functions in diabetic patients. Diabet. Med. 14(1), 29–34 (1997)
R. Otton, J.R. Mendonça, R. Curi, Diabetes causes marked changes in lymphocyte metabolism. J. Endocrinol. 174, 55–61 (2002)
R. Curi, P. Newsholme, T.C. Pithon-Curi, M. Pires-de-Melo, C. Garcia, P.I. Homem-de-Bittencourt Jr., A.R.P. Guimarães, Metabolic fate of glutamine in lymphocytes, macrophages and neutrophils. Braz. J. Med. Biol. Res. 32, 15–21 (1999)
D. Reinhold, S. Ansorge, E.D. Schleicher, Elevated glucose levels stimulate transforming growth factor-_1 (TGF-_1), suppress interleukin IL-2, IL-6 and IL-10 production and DNA synthesis in peripheral blood mononuclear cells. Horm. Metab. Res. 28, 267–270 (1996)
R.E. Dolkart, B. Halpern, J. Perlman, Comparison of antibody responses in normal and alloxan diabetic mice. Diabetes 20, 162–167 (1971)
A.A. Mahmoud, H.M. Rodman, M.A. Mandel, K.S. Warren, Induced and spontaneous diabetes mellitus and suppression of cell-mediated immunological responses. J. Clin. Invest. 57, 362–367 (1976)
J.D. Bybee, D.E. Rogers, The phagocytic activity of polymorphonuclear leukocytes obtained from patients with diabetes mellitus. J. Lab. Clin. Med. 61, 1–13 (1964)
J.D. Bagdade, K.L. Neilson, R.J. Bugler, Reversible abnormalities in phagocytic function in poorly controlled diabetic patients. Am. J. Med. Sci. 263, 451–456 (1972)
S. Katz, B. Klein, I. Elian, P. Fishman, M. Djaldetti, Phagocytotic activity of monocytes from diabetic patients. Diabetes Care 6, 479–482 (1983)
D. Tater, B. Tepaut, J.P. Bercovici, P. Youinou, Polymorphonuclear cell derangements in type 1 diabetes. Horm. Metab. Res. 19, 642–647 (1987)
American diabetes association. Diagnosis and classification of diabetes Mellitus Diabetes care, vol 29, supplement 1, January, 2006
K.G. Alberti, P.Z. Zimmet, Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabet. Med. 15, 539–553 (1998)
W.T. Friedewald, R.I. Levy, D.S. Fredrickson, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499–502 (1978)
L. Kenar, H. Boyunaga, M. Serdar, T. Karayilanoglu, M.K. Erbil, Effect of nitrogen mustard, a vesicant agent, on lymphocyte energy metabolism. Clin. Chem. Lab. Med. 44(10), 1253–1257 (2006)
A. Koller, L.A. Kaplan, Total serum protein, in: Methods in Clinical Chemistry, ed. by A.J. Pesce, L.A. Kaplan (Mosby, St. Louis, MO, 1987), pp. 1134–1144
H.R. Horton, L.A. Moran, R.S. Ochs, J.D. Rawn, K.G. Scrimgeour, Principles of Biochemistry. (Prentice Hall, Upper Saddle River, NJ, 2002)
W.Z. Hassid, S. Abraham, Chemical procedures for analysis of polysaccharides, in Methods in Enzymology, vol. 3, ed. by S.P. Colowick, N.O. Kaplan (Academic Press, New York, 1957), pp. 34–37
R.K. Murray, P.A. Mayes, D.K. Granner, V.W. Rodwell, Harper’s Biochemistry, 24th edn. (Prentice Hall, New Jersey, 1996)
Y. Ishida, K. Takagi-Ohta, Lactate production of mammalian intestinal and vascular smooth muscles under aerobic and hypoxic conditions. J. Smooth Muscle Res. 32(2), 61–67 (1996)
N.J. MacIver, S.R. Jacobs, H.L. Wieman, J.A. Wofford, J.L. Coloff, J.C. Rathmell, Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival. J. Leukoc. Biol. 84, 949 (2008)
V.R. Moreno-Aurioles, R. Montaño, M. Conde, R. Bustos, F. Sobrino, Streptozotocin-induced diabetes increases fructose 2, 6-biphosphate levels and glucose metabolism in thymus lymphocytes. Life Sci 58, 477–484 (1996)
P.C. Champe, R.A. Harvey, D.R. Ferrier, Glycolysis. in: Lippincott’s Illustrated Reviews: Biochemistry, 3rd edn. ed. by P. Champe, R. Harvey, D. Ferrier (Lippincott Williams & Wilkins: Philadelphia, PA, 2004), pp. 89–106
T.C. Alba-Loureiro, S.M. Hirabara, J.R. Mendonça, R. Curi, T.C. Pithon-Curi, Diabetes causes marked changes in function and metabolism of rat neutrophils. J. Endocrinol. 188, 295–303 (2006)
K.P. Bouter, F.H. Meyling, J.B. Hoekstra, N. Masurel, D.W. Erkelens, R.J. Diepersloot, Influence of blood glucose levels on peripheral lymphocytes in patients with diabetes mellitus. Diabetes Res 19(2), 77–80 (1992)
E.S. Kopeć, Effect of metabolically uncompensated diabetes mellitus on mononuclear cell populations in peripheral blood. Pol. Arch. Med. Wewn. 87(4–5), 277–284 (1992)
P. Newsholme, R. Curi, T.C. Pithon Curi, C.J. Murphy, C. Garcia, M. Pires-de-Melo, Glutamine metabolism by lymphocytes, macrophages, and neutrophils: its importance in health and disease. J. Nutr. Biochem. 10, 316–324 (1999)
S. Walrand, C. Guillet, Y. Boirie, M.-P. Vasson. Insulin differentially regulates monocyte and polymorphonuclear neutrophil functions in healthy young and elderly humans. J. Clin. Endocrinol. Metab. 91(7):2738–2748
The Diabetes Control and Complications Trial Research Group, The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329, 977–986 (1993)
UKProspective Diabetes Study (UKPDS) Group, Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352, 854–865 (1998)
UKProspective Diabetes Study (UKPDS) Group, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352, 837–853 (1998)
Author information
Authors and Affiliations
Corresponding author
Additional information
An erratum to this article is available at http://dx.doi.org/10.1007/s12020-010-9349-x.
Rights and permissions
About this article
Cite this article
Ozsari, L., Karadurmus, N., Sahin, M. et al. Comparison of lymphomononuclear cell energy metabolism between healthy, impaired glucose intolerance and type 2 diabetes mellitus patients. Endocr 37, 135–139 (2010). https://doi.org/10.1007/s12020-009-9281-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-009-9281-0